dc.contributor.author | Rescigno, P | |
dc.date.accessioned | 2020-07-09T12:29:11Z | |
dc.date.issued | 2019-11-01 | |
dc.identifier | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000508429900002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9 | |
dc.identifier | ARTN IJE18 | |
dc.identifier.citation | INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2019, 6 (3), pp. ? - ? (3) | |
dc.identifier.issn | 2045-0869 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/3843 | |
dc.identifier.eissn | 2045-0877 | |
dc.identifier.doi | 10.2217/ije-2019-0010 | |
dc.format.extent | ? - ? (3) | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | FUTURE MEDICINE LTD | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.subject | Science & Technology | |
dc.subject | Life Sciences & Biomedicine | |
dc.subject | Oncology | |
dc.title | The treatment of neuroendocrine prostate cancer; current status and future directions | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.2217/ije-2019-0010 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2019-11-01 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY | |
pubs.declined | 2020-07-09T13:27:51.979+0100 | |
pubs.issue | 3 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
pubs.publication-status | Published | |
pubs.volume | 6 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Prostate Cancer Targeted Therapy Group | en_US |
dc.contributor.icrauthor | Rescigno, Pasquale | |